Dr. Raymond K. Hsu, MD

Dr. Hsu practices at Surgical Suite LLC in San Francisco, California.

Dr. Hsu's NPI, 1124139167, was assigned on August 31, 2006. Dr. Hsu graduated from Feinberg School of Medicine in 2005. Dr. Hsu holds California license A108247.

Dr. Hsu's primary practice is Surgical Suite LLC, at 1700 California St, San Francisco, CA 94109 in San Francisco County. The practice phone is (415) 567-1791.

Dr. Hsu's primary practice is Surgical Suite LLC in San Francisco, California. Dr. Hsu is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Hsu to 4 more dialysis centers, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hsu practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Hsu's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Hsu is board certified in nephrology by the American Board of Internal Medicine. Dr. Hsu is licensed in California.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Hsu treats.

CMS data shows 856 Medicare services from Dr. Hsu across 12 procedure codes in 2024, for 246 Medicare patients. Medicare paid $83,311 for them.

CMS counts 246 Medicare patients who saw Dr. Hsu in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 50% are also on Medicaid. Their average risk score is 4.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hsu's median patient age at 64, with 53% women.

In 2024, Dr. Hsu wrote 941 Medicare Part D claims for 114 patients. 75% of them were for generic drugs. CMS names the drug for 650 of them, across 21 drugs with 11 or more claims each, at $496,171 in total drug cost. In 2023, CMS named 680 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hsu for performance year 2024, reported as part of a group. Dr. Hsu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hsu as offering telehealth.

Dmand AI links 46 papers to Dr. Hsu, published from 2011 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Acute Kidney Injury, Renal Dialysis and Glomerular Filtration Rate. Dr. Hsu has published most often in Clin J Am Soc Nephrol. Dr. Hsu's most frequent co-authors are Chi-Yuan Hsu, MD, Kathleen D. Liu, MD and Alan S. Go, MD.

CMS Open Payments shows 104 general payments to Dr. Hsu from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Alexion Pharmaceuticals, Inc. paid the most, $46,412.

Dmand AI lists 1 award for Dr. Hsu, most recently CMS Stage 1 EHR in 2013.

Dr. Hsu graduated from Feinberg School of Medicine in 2005.

Dr. Hsu is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.